These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1267 related articles for article (PubMed ID: 28903767)

  • 1. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sequencing of the vaginal microbiota of women with HIV.
    Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
    PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis.
    Oyenihi AB; Haines R; Trama J; Faro S; Mordechai E; Adelson ME; Osei Sekyere J
    Front Cell Infect Microbiol; 2024; 14():1409774. PubMed ID: 39006741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.
    Qin H; Jiao J; A D; Hua M; Han K; Du H; Wang Z; Li J; Zhang D; Xiao B; Chen C
    Microbiol Spectr; 2023 Jun; 11(3):e0170622. PubMed ID: 37199621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.
    Dols JA; Molenaar D; van der Helm JJ; Caspers MP; de Kat Angelino-Bart A; Schuren FH; Speksnijder AG; Westerhoff HV; Richardus JH; Boon ME; Reid G; de Vries HJ; Kort R
    BMC Infect Dis; 2016 Apr; 16():180. PubMed ID: 27107961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
    Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
    Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women.
    Witkin SS; Moron AF; Linhares IM; Forney LJ
    Arch Gynecol Obstet; 2021 Aug; 304(2):395-400. PubMed ID: 33521838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study.
    Muzny CA; Blanchard E; Taylor CM; Aaron KJ; Talluri R; Griswold ME; Redden DT; Luo M; Welsh DA; Van Der Pol WJ; Lefkowitz EJ; Martin DH; Schwebke JR
    J Infect Dis; 2018 Aug; 218(6):966-978. PubMed ID: 29718358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.
    Cruciani F; Biagi E; Severgnini M; Consolandi C; Calanni F; Donders G; Brigidi P; Vitali B
    Antimicrob Agents Chemother; 2015 May; 59(5):2825-34. PubMed ID: 25733514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
    Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
    Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
    Lee CY; Cheu RK; Lemke MM; Gustin AT; France MT; Hampel B; Thurman AR; Doncel GF; Ravel J; Klatt NR; Arnold KB
    Nat Commun; 2020 Dec; 11(1):6147. PubMed ID: 33262350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Illumina sequencing 16S rRNA tagging reveals diverse vaginal microbiomes associated with bacterial vaginosis].
    Xu S; Zong L; Liu M; He Y; Huang X; Zhou H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):672-7. PubMed ID: 23688985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
    Tamarelle J; Ma B; Gajer P; Humphrys MS; Terplan M; Mark KS; Thiébaut ACM; Forney LJ; Brotman RM; Delarocque-Astagneau E; Bavoil PM; Ravel J
    J Infect Dis; 2020 Feb; 221(4):627-635. PubMed ID: 31573603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis.
    Ahrens P; Andersen LO; Lilje B; Johannesen TB; Dahl EG; Baig S; Jensen JS; Falk L
    PLoS One; 2020; 15(7):e0236036. PubMed ID: 32722712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women.
    Vodstrcil LA; Twin J; Garland SM; Fairley CK; Hocking JS; Law MG; Plummer EL; Fethers KA; Chow EP; Tabrizi SN; Bradshaw CS
    PLoS One; 2017; 12(2):e0171856. PubMed ID: 28234976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of contraceptive initiation on vaginal microbiota.
    Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
    Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Log (
    Deng T; Shang A; Zheng Y; Zhang L; Sun H; Wang W
    Bioengineered; 2022 Feb; 13(2):2981-2991. PubMed ID: 35038957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.